Brian Day
Concepts (546)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Antioxidants | 43 | 2024 | 581 | 6.550 |
Why?
| Glutathione | 28 | 2017 | 327 | 5.770 |
Why?
| Metalloporphyrins | 26 | 2024 | 109 | 4.250 |
Why?
| Oxidative Stress | 42 | 2024 | 1204 | 3.920 |
Why?
| Thiocyanates | 6 | 2019 | 31 | 2.160 |
Why?
| Bronchoalveolar Lavage Fluid | 15 | 2021 | 633 | 2.030 |
Why?
| Lung | 23 | 2023 | 3830 | 1.870 |
Why?
| Reactive Oxygen Species | 21 | 2018 | 592 | 1.860 |
Why?
| Mustard Gas | 7 | 2016 | 119 | 1.830 |
Why?
| Chemical Warfare Agents | 4 | 2016 | 127 | 1.750 |
Why?
| Particulate Matter | 4 | 2021 | 257 | 1.660 |
Why?
| ATP-Binding Cassette Transporters | 5 | 2012 | 128 | 1.460 |
Why?
| Smoking | 9 | 2015 | 1556 | 1.220 |
Why?
| Immunity, Innate | 3 | 2019 | 762 | 1.090 |
Why?
| Lung Injury | 4 | 2023 | 215 | 1.030 |
Why?
| Mesalamine | 2 | 2017 | 8 | 1.000 |
Why?
| Antidotes | 3 | 2016 | 160 | 0.990 |
Why?
| Cystic Fibrosis Transmembrane Conductance Regulator | 4 | 2012 | 302 | 0.980 |
Why?
| Flavonoids | 3 | 2011 | 73 | 0.980 |
Why?
| Lung Diseases | 4 | 2021 | 764 | 0.970 |
Why?
| Berylliosis | 4 | 2017 | 183 | 0.940 |
Why?
| Inflammation | 11 | 2020 | 2598 | 0.910 |
Why?
| Animals | 67 | 2024 | 34133 | 0.910 |
Why?
| Cystic Fibrosis | 4 | 2020 | 1003 | 0.900 |
Why?
| Tumor Necrosis Factor-alpha | 6 | 2023 | 1181 | 0.890 |
Why?
| Superoxide Dismutase | 12 | 2015 | 345 | 0.880 |
Why?
| Mitochondria | 11 | 2015 | 809 | 0.880 |
Why?
| Pneumonia | 2 | 2020 | 605 | 0.880 |
Why?
| Molecular Mimicry | 3 | 2008 | 40 | 0.790 |
Why?
| Acetylcysteine | 5 | 2016 | 150 | 0.760 |
Why?
| Interleukin-1 Receptor-Like 1 Protein | 1 | 2020 | 24 | 0.760 |
Why?
| Inhalation Exposure | 5 | 2016 | 111 | 0.750 |
Why?
| Interleukin-33 | 1 | 2020 | 39 | 0.750 |
Why?
| Oxidation-Reduction | 14 | 2017 | 931 | 0.730 |
Why?
| Thioredoxin-Disulfide Reductase | 3 | 2015 | 14 | 0.730 |
Why?
| Anti-Infective Agents | 2 | 2019 | 248 | 0.720 |
Why?
| Epithelial Cells | 9 | 2022 | 995 | 0.710 |
Why?
| Prodrugs | 1 | 2019 | 44 | 0.700 |
Why?
| Neuroprotective Agents | 5 | 2021 | 110 | 0.700 |
Why?
| Chalcones | 5 | 2012 | 9 | 0.690 |
Why?
| Neoplasm Proteins | 4 | 2014 | 415 | 0.680 |
Why?
| Mice | 35 | 2021 | 15888 | 0.660 |
Why?
| Inflammation Mediators | 5 | 2018 | 515 | 0.630 |
Why?
| Allergens | 1 | 2021 | 421 | 0.630 |
Why?
| Beryllium | 3 | 2009 | 152 | 0.620 |
Why?
| Anti-Bacterial Agents | 3 | 2019 | 1562 | 0.620 |
Why?
| Electronic Nicotine Delivery Systems | 3 | 2023 | 86 | 0.600 |
Why?
| Methicillin-Resistant Staphylococcus aureus | 1 | 2019 | 194 | 0.600 |
Why?
| Deoxyguanosine | 3 | 2016 | 25 | 0.590 |
Why?
| Organometallic Compounds | 2 | 2009 | 88 | 0.590 |
Why?
| Manganese | 4 | 2024 | 57 | 0.580 |
Why?
| Cell Line | 13 | 2020 | 2785 | 0.580 |
Why?
| Wound Healing | 1 | 2019 | 279 | 0.580 |
Why?
| Free Radical Scavengers | 6 | 2013 | 90 | 0.570 |
Why?
| Catalase | 4 | 2013 | 125 | 0.560 |
Why?
| Mice, Inbred C57BL | 17 | 2021 | 5020 | 0.560 |
Why?
| Industrial Waste | 1 | 2015 | 6 | 0.550 |
Why?
| War Exposure | 1 | 2015 | 11 | 0.550 |
Why?
| Immunity, Cellular | 1 | 2017 | 276 | 0.540 |
Why?
| Sarcoidosis, Pulmonary | 1 | 2016 | 55 | 0.530 |
Why?
| Reverse Transcriptase Inhibitors | 3 | 2004 | 85 | 0.530 |
Why?
| Peroxidases | 1 | 2015 | 26 | 0.520 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 302 | 0.510 |
Why?
| Respiratory Mucosa | 4 | 2011 | 263 | 0.510 |
Why?
| Lymphocytes | 3 | 2017 | 360 | 0.500 |
Why?
| NF-E2-Related Factor 2 | 2 | 2013 | 84 | 0.490 |
Why?
| Respiratory System | 1 | 2015 | 144 | 0.490 |
Why?
| Skin | 3 | 2014 | 694 | 0.480 |
Why?
| Afghanistan | 4 | 2021 | 126 | 0.460 |
Why?
| Rats, Sprague-Dawley | 14 | 2024 | 2501 | 0.460 |
Why?
| Cell Survival | 8 | 2014 | 1075 | 0.450 |
Why?
| Macrophages, Alveolar | 3 | 2011 | 364 | 0.440 |
Why?
| Cytokines | 7 | 2018 | 1928 | 0.440 |
Why?
| Cell Proliferation | 6 | 2017 | 2328 | 0.430 |
Why?
| Macrophage Inflammatory Proteins | 1 | 2012 | 12 | 0.430 |
Why?
| DNA, Mitochondrial | 4 | 2009 | 189 | 0.430 |
Why?
| Chemokines, CC | 1 | 2012 | 29 | 0.420 |
Why?
| Pinocytosis | 1 | 2011 | 11 | 0.420 |
Why?
| Nerve Agents | 2 | 2024 | 4 | 0.420 |
Why?
| Macrophages | 6 | 2020 | 1334 | 0.420 |
Why?
| Rats | 17 | 2024 | 5426 | 0.410 |
Why?
| Glutathione Peroxidase | 2 | 2008 | 53 | 0.410 |
Why?
| Chalcone | 1 | 2011 | 3 | 0.410 |
Why?
| Influenza A virus | 2 | 2023 | 112 | 0.410 |
Why?
| Anti-Inflammatory Agents | 1 | 2015 | 469 | 0.410 |
Why?
| Extracellular Space | 2 | 2011 | 132 | 0.410 |
Why?
| DNA | 4 | 2016 | 1401 | 0.410 |
Why?
| Antibiotics, Antineoplastic | 2 | 2011 | 115 | 0.400 |
Why?
| Smoke | 3 | 2013 | 146 | 0.400 |
Why?
| Environmental Exposure | 1 | 2015 | 427 | 0.400 |
Why?
| JNK Mitogen-Activated Protein Kinases | 2 | 2011 | 156 | 0.400 |
Why?
| Humans | 53 | 2023 | 122796 | 0.390 |
Why?
| Membrane Transport Proteins | 1 | 2012 | 137 | 0.390 |
Why?
| Doxorubicin | 2 | 2011 | 304 | 0.390 |
Why?
| Adaptation, Physiological | 2 | 2011 | 510 | 0.380 |
Why?
| Macrophage Activation | 1 | 2011 | 169 | 0.380 |
Why?
| Virus Diseases | 2 | 2023 | 201 | 0.380 |
Why?
| Sulfasalazine | 1 | 2009 | 21 | 0.360 |
Why?
| Chelating Agents | 1 | 2009 | 75 | 0.360 |
Why?
| Lung Neoplasms | 4 | 2011 | 2216 | 0.350 |
Why?
| Prostaglandin D2 | 1 | 2009 | 23 | 0.350 |
Why?
| Mitochondrial Diseases | 1 | 2009 | 79 | 0.340 |
Why?
| Cell Line, Tumor | 8 | 2012 | 2904 | 0.340 |
Why?
| Adenosine Triphosphate | 2 | 2015 | 456 | 0.340 |
Why?
| Oxidants | 4 | 2019 | 126 | 0.340 |
Why?
| Status Epilepticus | 3 | 2017 | 34 | 0.330 |
Why?
| Mitochondrial Membranes | 1 | 2008 | 38 | 0.330 |
Why?
| Male | 36 | 2021 | 59639 | 0.330 |
Why?
| Pseudomonas Infections | 2 | 2015 | 198 | 0.330 |
Why?
| Mycoplasma pneumoniae | 1 | 2008 | 33 | 0.330 |
Why?
| NADPH-Ferrihemoprotein Reductase | 2 | 2005 | 11 | 0.320 |
Why?
| Mice, Inbred CFTR | 4 | 2012 | 5 | 0.320 |
Why?
| Chlorine | 3 | 2015 | 61 | 0.320 |
Why?
| Lymphocyte Activation | 3 | 2009 | 1148 | 0.310 |
Why?
| Chromatography, High Pressure Liquid | 5 | 2011 | 493 | 0.310 |
Why?
| Apoptosis | 9 | 2015 | 2532 | 0.310 |
Why?
| Gene Expression Regulation | 4 | 2020 | 2491 | 0.310 |
Why?
| Mitochondria, Liver | 2 | 2004 | 77 | 0.300 |
Why?
| Drug Resistance, Neoplasm | 2 | 2011 | 673 | 0.290 |
Why?
| Peroxidase | 3 | 2020 | 182 | 0.290 |
Why?
| Influenza, Human | 2 | 2023 | 566 | 0.290 |
Why?
| Cisplatin | 1 | 2007 | 269 | 0.270 |
Why?
| Carrier Proteins | 1 | 2010 | 740 | 0.270 |
Why?
| Pulmonary Disease, Chronic Obstructive | 4 | 2011 | 1265 | 0.270 |
Why?
| Administration, Oral | 5 | 2021 | 786 | 0.270 |
Why?
| Epilepsy, Temporal Lobe | 2 | 2015 | 20 | 0.260 |
Why?
| Mice, Knockout | 10 | 2015 | 2737 | 0.260 |
Why?
| Microsomes, Liver | 1 | 2005 | 59 | 0.260 |
Why?
| Hydrogen Peroxide | 5 | 2012 | 299 | 0.260 |
Why?
| Neoplasms | 3 | 2014 | 2235 | 0.260 |
Why?
| Pulmonary Fibrosis | 1 | 2008 | 305 | 0.260 |
Why?
| Stavudine | 1 | 2004 | 9 | 0.260 |
Why?
| Chronic Disease | 6 | 2017 | 1645 | 0.250 |
Why?
| Disease Models, Animal | 11 | 2021 | 3799 | 0.250 |
Why?
| Hippocampus | 4 | 2017 | 747 | 0.250 |
Why?
| Monocytes | 2 | 2021 | 523 | 0.250 |
Why?
| Flavins | 1 | 2004 | 1 | 0.250 |
Why?
| Nucleosides | 1 | 2004 | 26 | 0.240 |
Why?
| Head and Neck Neoplasms | 1 | 2009 | 475 | 0.240 |
Why?
| Lipid Peroxidation | 7 | 2007 | 151 | 0.240 |
Why?
| Pulmonary Edema | 1 | 2003 | 141 | 0.230 |
Why?
| Bronchoalveolar Lavage | 2 | 2021 | 98 | 0.220 |
Why?
| DNA Replication | 1 | 2004 | 214 | 0.220 |
Why?
| Anticonvulsants | 2 | 2017 | 189 | 0.220 |
Why?
| Double-Blind Method | 2 | 2017 | 1711 | 0.210 |
Why?
| Vaping | 1 | 2023 | 53 | 0.210 |
Why?
| Signal Transduction | 6 | 2020 | 4902 | 0.210 |
Why?
| Spectrophotometry, Ultraviolet | 1 | 2002 | 76 | 0.210 |
Why?
| Cells, Cultured | 8 | 2018 | 4162 | 0.210 |
Why?
| Electrochemistry | 1 | 2002 | 71 | 0.210 |
Why?
| Lipopolysaccharides | 4 | 2016 | 875 | 0.210 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2008 | 1003 | 0.210 |
Why?
| Structure-Activity Relationship | 5 | 2012 | 536 | 0.200 |
Why?
| Substrate Specificity | 3 | 2013 | 375 | 0.200 |
Why?
| Pulmonary Alveoli | 2 | 2020 | 395 | 0.200 |
Why?
| Administration, Inhalation | 3 | 2015 | 664 | 0.190 |
Why?
| Thiobarbituric Acid Reactive Substances | 4 | 2007 | 24 | 0.190 |
Why?
| Parkinsonian Disorders | 1 | 2021 | 29 | 0.190 |
Why?
| Oxygen | 4 | 2015 | 887 | 0.190 |
Why?
| Dose-Response Relationship, Drug | 8 | 2016 | 1981 | 0.190 |
Why?
| Aging | 2 | 2010 | 1694 | 0.190 |
Why?
| Adenocarcinoma | 1 | 2007 | 837 | 0.190 |
Why?
| Burkholderia | 1 | 2020 | 13 | 0.190 |
Why?
| Antineoplastic Agents | 2 | 2012 | 1990 | 0.190 |
Why?
| Brain | 3 | 2018 | 2540 | 0.180 |
Why?
| Cyanates | 1 | 2019 | 4 | 0.180 |
Why?
| Selenium Compounds | 1 | 2019 | 21 | 0.180 |
Why?
| Drug Evaluation, Preclinical | 3 | 2017 | 187 | 0.180 |
Why?
| Glutamate-Cysteine Ligase | 2 | 2017 | 18 | 0.180 |
Why?
| Middle Aged | 9 | 2018 | 28563 | 0.180 |
Why?
| MPTP Poisoning | 2 | 2017 | 4 | 0.170 |
Why?
| Cognitive Dysfunction | 1 | 2024 | 309 | 0.170 |
Why?
| Particle Size | 1 | 2020 | 344 | 0.170 |
Why?
| Mice, Hairless | 3 | 2014 | 74 | 0.170 |
Why?
| Morbidity | 1 | 2020 | 309 | 0.170 |
Why?
| Sequence Analysis, RNA | 1 | 2021 | 420 | 0.170 |
Why?
| Isoflurophate | 1 | 2018 | 6 | 0.160 |
Why?
| Drug Synergism | 3 | 2012 | 346 | 0.160 |
Why?
| Pseudomonas aeruginosa | 2 | 2015 | 310 | 0.160 |
Why?
| Neurotoxicity Syndromes | 1 | 2018 | 16 | 0.160 |
Why?
| Interleukin-13 | 1 | 2018 | 138 | 0.160 |
Why?
| Female | 18 | 2018 | 63629 | 0.160 |
Why?
| Dimercaprol | 1 | 2017 | 7 | 0.150 |
Why?
| Antiparkinson Agents | 1 | 2017 | 28 | 0.150 |
Why?
| Neutrophils | 3 | 2020 | 1246 | 0.150 |
Why?
| Kinetics | 2 | 2013 | 1658 | 0.150 |
Why?
| Catalysis | 3 | 2008 | 295 | 0.150 |
Why?
| Auranofin | 2 | 2013 | 9 | 0.150 |
Why?
| Reactive Nitrogen Species | 2 | 2018 | 27 | 0.140 |
Why?
| Tumor Cells, Cultured | 2 | 2011 | 904 | 0.140 |
Why?
| Cornea | 2 | 2007 | 120 | 0.140 |
Why?
| Sulfhydryl Compounds | 2 | 2017 | 190 | 0.140 |
Why?
| Aldehyde Dehydrogenase | 2 | 2007 | 135 | 0.140 |
Why?
| Age Factors | 2 | 2015 | 3114 | 0.130 |
Why?
| Neurons | 3 | 2018 | 1345 | 0.130 |
Why?
| Aged | 5 | 2018 | 20495 | 0.130 |
Why?
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2015 | 38 | 0.130 |
Why?
| Leukocytes, Mononuclear | 1 | 2017 | 514 | 0.130 |
Why?
| Intracellular Space | 2 | 2012 | 72 | 0.130 |
Why?
| Thiourea | 2 | 2013 | 39 | 0.130 |
Why?
| Matrix Metalloproteinases | 1 | 2015 | 91 | 0.130 |
Why?
| Comet Assay | 1 | 2014 | 17 | 0.130 |
Why?
| Drug Resistance, Multiple | 1 | 2014 | 19 | 0.120 |
Why?
| Response Elements | 2 | 2012 | 85 | 0.120 |
Why?
| Mice, Inbred BALB C | 4 | 2013 | 1245 | 0.120 |
Why?
| DNA-Directed DNA Polymerase | 2 | 2006 | 45 | 0.120 |
Why?
| Pneumonia, Bacterial | 1 | 2015 | 113 | 0.120 |
Why?
| Transcription Factor AP-1 | 2 | 2011 | 82 | 0.120 |
Why?
| DNA Damage | 4 | 2009 | 368 | 0.120 |
Why?
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2014 | 105 | 0.120 |
Why?
| Adult | 7 | 2016 | 32385 | 0.120 |
Why?
| Selenocysteine | 1 | 2013 | 3 | 0.120 |
Why?
| Glycolysis | 1 | 2015 | 227 | 0.120 |
Why?
| Pollen | 1 | 2013 | 27 | 0.120 |
Why?
| Hypochlorous Acid | 1 | 2013 | 7 | 0.120 |
Why?
| Cytoprotection | 2 | 2013 | 58 | 0.120 |
Why?
| Bronchioles | 1 | 2013 | 23 | 0.120 |
Why?
| Adaptor Proteins, Vesicular Transport | 1 | 2013 | 49 | 0.110 |
Why?
| Thioredoxin Reductase 2 | 1 | 2012 | 2 | 0.110 |
Why?
| Biomarkers | 5 | 2018 | 3662 | 0.110 |
Why?
| NADPH Oxidases | 1 | 2013 | 141 | 0.110 |
Why?
| Microbial Viability | 1 | 2013 | 82 | 0.110 |
Why?
| L-Lactate Dehydrogenase | 2 | 2010 | 114 | 0.110 |
Why?
| MAP Kinase Signaling System | 2 | 2017 | 304 | 0.110 |
Why?
| Bacteria | 1 | 2019 | 772 | 0.110 |
Why?
| Antigens | 1 | 2014 | 337 | 0.110 |
Why?
| Dopaminergic Neurons | 1 | 2012 | 45 | 0.110 |
Why?
| Amino Acid Substitution | 1 | 2013 | 278 | 0.110 |
Why?
| Alveolar Epithelial Cells | 1 | 2013 | 98 | 0.110 |
Why?
| Immunohistochemistry | 4 | 2010 | 1727 | 0.110 |
Why?
| In Vitro Techniques | 2 | 2005 | 1130 | 0.110 |
Why?
| Transcriptional Activation | 2 | 2011 | 360 | 0.110 |
Why?
| Random Allocation | 4 | 2017 | 360 | 0.110 |
Why?
| Cysteine | 1 | 2013 | 187 | 0.110 |
Why?
| Extracellular Fluid | 1 | 2011 | 32 | 0.100 |
Why?
| Heart Diseases | 1 | 2015 | 358 | 0.100 |
Why?
| Antigen-Presenting Cells | 2 | 2009 | 157 | 0.100 |
Why?
| Blood-Brain Barrier | 3 | 2021 | 107 | 0.100 |
Why?
| Fumarate Hydratase | 2 | 2011 | 2 | 0.100 |
Why?
| Copper | 2 | 2009 | 101 | 0.100 |
Why?
| Molecular Targeted Therapy | 1 | 2014 | 361 | 0.100 |
Why?
| Aconitate Hydratase | 2 | 2011 | 17 | 0.100 |
Why?
| Nasal Cavity | 1 | 2011 | 51 | 0.100 |
Why?
| Phagocytosis | 2 | 2012 | 368 | 0.100 |
Why?
| Olfactory Mucosa | 1 | 2011 | 59 | 0.100 |
Why?
| Cognition Disorders | 1 | 2015 | 547 | 0.100 |
Why?
| Irritants | 1 | 2010 | 45 | 0.090 |
Why?
| Myocardium | 3 | 2015 | 982 | 0.090 |
Why?
| Toll-Like Receptor 4 | 1 | 2013 | 335 | 0.090 |
Why?
| Asthma | 3 | 2013 | 2130 | 0.090 |
Why?
| Dopamine | 2 | 2017 | 250 | 0.090 |
Why?
| Bronchi | 1 | 2012 | 253 | 0.090 |
Why?
| Apoproteins | 1 | 2009 | 11 | 0.090 |
Why?
| HIV Infections | 2 | 2004 | 2532 | 0.090 |
Why?
| Peptide Fragments | 1 | 2014 | 715 | 0.090 |
Why?
| Electron Transport | 1 | 2009 | 101 | 0.090 |
Why?
| Heme Oxygenase-1 | 1 | 2009 | 52 | 0.090 |
Why?
| Dermatitis, Irritant | 1 | 2009 | 12 | 0.090 |
Why?
| Electron Spin Resonance Spectroscopy | 1 | 2009 | 78 | 0.090 |
Why?
| tert-Butylhydroperoxide | 1 | 2009 | 10 | 0.090 |
Why?
| Mice, Inbred Strains | 1 | 2010 | 418 | 0.090 |
Why?
| Fluorescent Dyes | 1 | 2011 | 319 | 0.090 |
Why?
| Fungal Proteins | 1 | 2010 | 132 | 0.090 |
Why?
| Paraquat | 2 | 2012 | 13 | 0.090 |
Why?
| Biological Transport | 1 | 2010 | 392 | 0.080 |
Why?
| Demography | 1 | 2009 | 290 | 0.080 |
Why?
| rho GTP-Binding Proteins | 1 | 2009 | 68 | 0.080 |
Why?
| Biocatalysis | 1 | 2008 | 67 | 0.080 |
Why?
| Pneumonia, Mycoplasma | 1 | 2008 | 33 | 0.080 |
Why?
| Body Fluids | 1 | 2008 | 66 | 0.080 |
Why?
| Amino Acids | 2 | 2010 | 463 | 0.080 |
Why?
| Benzimidazoles | 1 | 2009 | 142 | 0.080 |
Why?
| Iron | 1 | 2009 | 239 | 0.080 |
Why?
| Interferon-gamma | 2 | 2009 | 747 | 0.080 |
Why?
| Sensitivity and Specificity | 2 | 2003 | 1855 | 0.080 |
Why?
| Epilepsy | 1 | 2011 | 291 | 0.080 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 1003 | 0.080 |
Why?
| Electron Transport Complex I | 1 | 2007 | 37 | 0.080 |
Why?
| Neurofibromin 1 | 1 | 2007 | 22 | 0.080 |
Why?
| Bacterial Proteins | 1 | 2013 | 775 | 0.080 |
Why?
| Eye Proteins | 1 | 2007 | 77 | 0.070 |
Why?
| Radiation-Protective Agents | 1 | 2007 | 28 | 0.070 |
Why?
| Radiation Injuries, Experimental | 1 | 2007 | 24 | 0.070 |
Why?
| Fibrosis | 1 | 2009 | 497 | 0.070 |
Why?
| Antiviral Agents | 2 | 2023 | 670 | 0.070 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 783 | 0.070 |
Why?
| Neurofibromatosis 1 | 1 | 2007 | 37 | 0.070 |
Why?
| Intestinal Absorption | 1 | 2007 | 106 | 0.070 |
Why?
| Time Factors | 2 | 2016 | 6682 | 0.070 |
Why?
| Pilocarpine | 2 | 2017 | 8 | 0.070 |
Why?
| Cell Fractionation | 1 | 2006 | 58 | 0.070 |
Why?
| Dexamethasone | 2 | 2012 | 323 | 0.070 |
Why?
| Quality of Life | 1 | 2017 | 2457 | 0.070 |
Why?
| HL-60 Cells | 1 | 2006 | 30 | 0.070 |
Why?
| Mycoplasma Infections | 1 | 2006 | 13 | 0.070 |
Why?
| Stromal Cells | 1 | 2006 | 103 | 0.070 |
Why?
| Leukemia, Myeloid | 1 | 2006 | 43 | 0.070 |
Why?
| Flow Cytometry | 1 | 2009 | 1128 | 0.070 |
Why?
| Corpus Striatum | 1 | 2007 | 130 | 0.070 |
Why?
| Saccharomyces cerevisiae | 1 | 2010 | 507 | 0.070 |
Why?
| Longevity | 1 | 2007 | 156 | 0.070 |
Why?
| Radiation Injuries | 1 | 2007 | 137 | 0.070 |
Why?
| Lens, Crystalline | 1 | 2007 | 126 | 0.070 |
Why?
| Cytochrome P-450 CYP2B1 | 1 | 2005 | 2 | 0.070 |
Why?
| Cytochrome P-450 Enzyme Inhibitors | 1 | 2005 | 4 | 0.070 |
Why?
| Caspase 8 | 1 | 2005 | 49 | 0.070 |
Why?
| Drosophila melanogaster | 1 | 2007 | 202 | 0.070 |
Why?
| Xenobiotics | 1 | 2005 | 26 | 0.060 |
Why?
| Cations | 1 | 2005 | 80 | 0.060 |
Why?
| Models, Biological | 2 | 2010 | 1756 | 0.060 |
Why?
| Aldehydes | 3 | 2012 | 155 | 0.060 |
Why?
| Young Adult | 2 | 2023 | 11094 | 0.060 |
Why?
| Nitric Oxide Synthase | 2 | 2003 | 227 | 0.060 |
Why?
| Cytochrome P-450 Enzyme System | 1 | 2005 | 113 | 0.060 |
Why?
| Cataract | 1 | 2007 | 194 | 0.060 |
Why?
| Oxidoreductases | 1 | 2005 | 101 | 0.060 |
Why?
| Ferritins | 1 | 2004 | 61 | 0.060 |
Why?
| Reperfusion Injury | 1 | 2007 | 279 | 0.060 |
Why?
| Insulin | 1 | 2014 | 2180 | 0.060 |
Why?
| Cell Respiration | 2 | 2015 | 78 | 0.060 |
Why?
| Liver Diseases | 1 | 2007 | 325 | 0.060 |
Why?
| Caspases | 1 | 2005 | 275 | 0.060 |
Why?
| Glyoxylates | 1 | 2003 | 9 | 0.060 |
Why?
| RNA, Small Interfering | 2 | 2018 | 581 | 0.060 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2009 | 1183 | 0.060 |
Why?
| Ischemia | 1 | 2007 | 382 | 0.060 |
Why?
| Sulfonylurea Compounds | 1 | 2003 | 43 | 0.060 |
Why?
| Hypertension | 1 | 2012 | 1245 | 0.060 |
Why?
| Organophosphates | 1 | 2024 | 94 | 0.060 |
Why?
| Disease Progression | 1 | 2010 | 2546 | 0.060 |
Why?
| Half-Life | 2 | 2017 | 147 | 0.060 |
Why?
| Parkinson Disease | 1 | 2007 | 346 | 0.060 |
Why?
| Confidence Intervals | 1 | 2003 | 339 | 0.050 |
Why?
| Carcinoma, Hepatocellular | 1 | 2004 | 231 | 0.050 |
Why?
| Probability | 1 | 2003 | 316 | 0.050 |
Why?
| Statistics, Nonparametric | 1 | 2003 | 416 | 0.050 |
Why?
| Cell Death | 2 | 2015 | 345 | 0.050 |
Why?
| Cardiomyopathies | 1 | 2006 | 308 | 0.050 |
Why?
| Nitric Acid | 1 | 2002 | 6 | 0.050 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2003 | 153 | 0.050 |
Why?
| Endotoxemia | 1 | 2003 | 93 | 0.050 |
Why?
| Molecular Structure | 1 | 2003 | 463 | 0.050 |
Why?
| Reference Values | 1 | 2003 | 789 | 0.050 |
Why?
| Antiretroviral Therapy, Highly Active | 1 | 2003 | 261 | 0.050 |
Why?
| Adolescent | 2 | 2023 | 18948 | 0.050 |
Why?
| Iraq | 1 | 2021 | 95 | 0.050 |
Why?
| Adjuvants, Immunologic | 1 | 2003 | 211 | 0.050 |
Why?
| Polymerase Chain Reaction | 1 | 2004 | 1021 | 0.050 |
Why?
| Recombinant Proteins | 1 | 2005 | 1318 | 0.050 |
Why?
| Epithelium | 1 | 2022 | 309 | 0.050 |
Why?
| Injury Severity Score | 1 | 2003 | 541 | 0.050 |
Why?
| Mitochondria, Heart | 2 | 2015 | 85 | 0.050 |
Why?
| Antibodies, Neutralizing | 1 | 2023 | 229 | 0.050 |
Why?
| Eosinophils | 1 | 2003 | 273 | 0.050 |
Why?
| Tissue Distribution | 1 | 2021 | 339 | 0.050 |
Why?
| Glutathione Disulfide | 2 | 2011 | 29 | 0.050 |
Why?
| Estrogens | 1 | 2002 | 325 | 0.040 |
Why?
| Enzyme Activation | 2 | 2017 | 864 | 0.040 |
Why?
| Obesity | 1 | 2012 | 2786 | 0.040 |
Why?
| Soman | 1 | 2018 | 1 | 0.040 |
Why?
| Polyethylene Glycols | 1 | 2024 | 560 | 0.040 |
Why?
| Interleukin-1 Receptor-Associated Kinases | 1 | 2018 | 21 | 0.040 |
Why?
| Clinical Trials as Topic | 1 | 2004 | 985 | 0.040 |
Why?
| Intensive Care Units | 1 | 2003 | 664 | 0.040 |
Why?
| Blood Pressure | 2 | 2003 | 1713 | 0.040 |
Why?
| Bronchial Diseases | 1 | 2018 | 35 | 0.040 |
Why?
| Prostatic Neoplasms | 1 | 2006 | 964 | 0.040 |
Why?
| Cohort Studies | 2 | 2012 | 5294 | 0.040 |
Why?
| Tyrosine | 2 | 2011 | 267 | 0.040 |
Why?
| Liver | 1 | 2007 | 1827 | 0.040 |
Why?
| Bronchopulmonary Dysplasia | 1 | 2003 | 337 | 0.040 |
Why?
| Toll-Like Receptor 2 | 1 | 2018 | 131 | 0.040 |
Why?
| Healthy Volunteers | 1 | 2018 | 209 | 0.040 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2006 | 1402 | 0.040 |
Why?
| Interleukin-8 | 1 | 2018 | 256 | 0.040 |
Why?
| T-Lymphocytes | 2 | 2004 | 1814 | 0.040 |
Why?
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 2017 | 2 | 0.040 |
Why?
| Nitric Oxide | 1 | 2003 | 884 | 0.040 |
Why?
| Rotarod Performance Test | 1 | 2017 | 17 | 0.040 |
Why?
| Gene Expression | 2 | 2013 | 1506 | 0.040 |
Why?
| Mice, Inbred NOD | 2 | 2014 | 588 | 0.040 |
Why?
| Blotting, Western | 2 | 2011 | 1225 | 0.040 |
Why?
| Nitric Oxide Synthase Type II | 2 | 2011 | 171 | 0.040 |
Why?
| Injections, Intraperitoneal | 1 | 2017 | 107 | 0.040 |
Why?
| Transfection | 2 | 2012 | 909 | 0.040 |
Why?
| Biological Availability | 1 | 2017 | 129 | 0.040 |
Why?
| RNA | 1 | 2023 | 854 | 0.040 |
Why?
| Nervous System | 1 | 2017 | 67 | 0.040 |
Why?
| Capillary Permeability | 1 | 2017 | 148 | 0.040 |
Why?
| Microglia | 1 | 2018 | 214 | 0.040 |
Why?
| Proteins | 1 | 2003 | 953 | 0.040 |
Why?
| Drug Design | 1 | 2017 | 163 | 0.030 |
Why?
| Case-Control Studies | 1 | 2003 | 3296 | 0.030 |
Why?
| Etiocholanolone | 1 | 2015 | 7 | 0.030 |
Why?
| Nootropic Agents | 1 | 2015 | 28 | 0.030 |
Why?
| Acute Kidney Injury | 1 | 2003 | 755 | 0.030 |
Why?
| Ranolazine | 1 | 2015 | 23 | 0.030 |
Why?
| Prognosis | 1 | 2003 | 3563 | 0.030 |
Why?
| Kainic Acid | 1 | 2015 | 31 | 0.030 |
Why?
| Endothelium, Vascular | 1 | 2002 | 923 | 0.030 |
Why?
| Enzyme Inhibitors | 2 | 2012 | 836 | 0.030 |
Why?
| DNA Polymerase gamma | 2 | 2006 | 7 | 0.030 |
Why?
| Cardiotonic Agents | 1 | 2015 | 133 | 0.030 |
Why?
| Military Personnel | 1 | 2021 | 584 | 0.030 |
Why?
| Dimerization | 1 | 2014 | 184 | 0.030 |
Why?
| Betula | 1 | 2013 | 3 | 0.030 |
Why?
| Behavior, Animal | 1 | 2017 | 486 | 0.030 |
Why?
| Treatment Outcome | 1 | 2008 | 9692 | 0.030 |
Why?
| Oxidopamine | 1 | 2012 | 13 | 0.030 |
Why?
| PPAR delta | 1 | 2012 | 6 | 0.030 |
Why?
| Calcium Signaling | 1 | 2015 | 232 | 0.030 |
Why?
| Peroxiredoxins | 1 | 2012 | 23 | 0.030 |
Why?
| Dual Specificity Phosphatase 1 | 1 | 2012 | 31 | 0.030 |
Why?
| Interferon-beta | 1 | 2013 | 87 | 0.030 |
Why?
| Receptors, Chemokine | 1 | 2012 | 46 | 0.030 |
Why?
| Lentivirus | 1 | 2012 | 52 | 0.030 |
Why?
| Mesencephalon | 1 | 2012 | 57 | 0.030 |
Why?
| Papio | 2 | 2003 | 98 | 0.030 |
Why?
| Quantitative Structure-Activity Relationship | 1 | 2012 | 13 | 0.030 |
Why?
| NF-E2 Transcription Factor, p45 Subunit | 1 | 2012 | 3 | 0.030 |
Why?
| Coenzyme A | 1 | 2011 | 6 | 0.030 |
Why?
| Holoenzymes | 1 | 2012 | 23 | 0.030 |
Why?
| Th2 Cells | 1 | 2013 | 170 | 0.030 |
Why?
| Adenine Nucleotides | 1 | 2011 | 20 | 0.030 |
Why?
| Diabetes Mellitus, Type 1 | 2 | 2014 | 3388 | 0.030 |
Why?
| Motor Activity | 1 | 2017 | 679 | 0.030 |
Why?
| Emphysema | 1 | 2013 | 129 | 0.030 |
Why?
| Acute Disease | 1 | 2015 | 984 | 0.030 |
Why?
| Cardiovascular Diseases | 1 | 2004 | 1859 | 0.030 |
Why?
| Luciferases | 1 | 2012 | 150 | 0.030 |
Why?
| Gene Knockdown Techniques | 1 | 2012 | 322 | 0.030 |
Why?
| Prospective Studies | 1 | 2003 | 6704 | 0.030 |
Why?
| Receptors, Glucocorticoid | 1 | 2012 | 136 | 0.030 |
Why?
| NAD | 1 | 2011 | 68 | 0.030 |
Why?
| Genes, Reporter | 1 | 2012 | 274 | 0.020 |
Why?
| Cell Division | 2 | 2004 | 788 | 0.020 |
Why?
| Buthionine Sulfoximine | 1 | 2010 | 8 | 0.020 |
Why?
| Dermatitis | 1 | 2010 | 18 | 0.020 |
Why?
| Immunoenzyme Techniques | 1 | 2011 | 201 | 0.020 |
Why?
| Skinfold Thickness | 1 | 2010 | 49 | 0.020 |
Why?
| RNA, Messenger | 2 | 2012 | 2720 | 0.020 |
Why?
| Sputum | 1 | 2012 | 293 | 0.020 |
Why?
| Myocytes, Cardiac | 1 | 2015 | 483 | 0.020 |
Why?
| Deoxyadenosines | 1 | 2009 | 6 | 0.020 |
Why?
| Oncogene Protein v-akt | 1 | 2009 | 26 | 0.020 |
Why?
| Cyclic N-Oxides | 1 | 2009 | 31 | 0.020 |
Why?
| Fibroblasts | 2 | 2006 | 846 | 0.020 |
Why?
| Indoles | 1 | 2012 | 318 | 0.020 |
Why?
| Electroencephalography | 1 | 2011 | 408 | 0.020 |
Why?
| HEK293 Cells | 1 | 2012 | 651 | 0.020 |
Why?
| Animals, Newborn | 1 | 2011 | 825 | 0.020 |
Why?
| Mice, Inbred ICR | 1 | 2009 | 111 | 0.020 |
Why?
| rhoA GTP-Binding Protein | 1 | 2009 | 80 | 0.020 |
Why?
| Hypertrophy, Left Ventricular | 1 | 2009 | 112 | 0.020 |
Why?
| Oxidative Phosphorylation | 1 | 2009 | 160 | 0.020 |
Why?
| Respiratory Function Tests | 1 | 2010 | 563 | 0.020 |
Why?
| Phenotype | 2 | 2007 | 3070 | 0.020 |
Why?
| rho-Associated Kinases | 1 | 2009 | 85 | 0.020 |
Why?
| Analysis of Variance | 1 | 2011 | 1329 | 0.020 |
Why?
| Cerebral Cortex | 1 | 2011 | 430 | 0.020 |
Why?
| Glucocorticoids | 1 | 2012 | 554 | 0.020 |
Why?
| Cell Cycle | 1 | 2010 | 584 | 0.020 |
Why?
| Retinal Dehydrogenase | 1 | 2007 | 40 | 0.020 |
Why?
| Nitrosation | 1 | 2007 | 10 | 0.020 |
Why?
| Energy Metabolism | 1 | 2012 | 783 | 0.020 |
Why?
| Membrane Lipids | 1 | 2007 | 88 | 0.020 |
Why?
| Injections, Subcutaneous | 1 | 2007 | 137 | 0.020 |
Why?
| Models, Molecular | 1 | 2012 | 1443 | 0.020 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2007 | 140 | 0.020 |
Why?
| Mitomycin | 1 | 2006 | 27 | 0.020 |
Why?
| Aspartate Aminotransferases | 1 | 2007 | 96 | 0.020 |
Why?
| Echocardiography | 1 | 2009 | 591 | 0.020 |
Why?
| Rats, Inbred F344 | 1 | 2007 | 245 | 0.020 |
Why?
| Alanine Transaminase | 1 | 2007 | 152 | 0.020 |
Why?
| Animals, Genetically Modified | 1 | 2007 | 227 | 0.020 |
Why?
| Cell Count | 1 | 2007 | 319 | 0.020 |
Why?
| Etoposide | 1 | 2006 | 149 | 0.020 |
Why?
| Protein Binding | 2 | 2002 | 2010 | 0.020 |
Why?
| Lung Volume Measurements | 1 | 2006 | 51 | 0.020 |
Why?
| Cyclic AMP | 1 | 2007 | 260 | 0.020 |
Why?
| Transcription, Genetic | 1 | 2012 | 1355 | 0.020 |
Why?
| NF-kappa B | 1 | 2009 | 676 | 0.020 |
Why?
| Heart | 1 | 2009 | 649 | 0.020 |
Why?
| Rabbits | 1 | 2006 | 808 | 0.020 |
Why?
| Drug Administration Schedule | 1 | 2007 | 757 | 0.020 |
Why?
| Radioisotopes | 1 | 2004 | 36 | 0.020 |
Why?
| fas Receptor | 1 | 2004 | 95 | 0.020 |
Why?
| Ultraviolet Rays | 1 | 2007 | 413 | 0.020 |
Why?
| Phagocytes | 1 | 2004 | 93 | 0.010 |
Why?
| Renal Blood Flow, Effective | 1 | 2003 | 3 | 0.010 |
Why?
| Antigen Presentation | 1 | 2004 | 198 | 0.010 |
Why?
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2003 | 13 | 0.010 |
Why?
| Dose-Response Relationship, Immunologic | 1 | 2003 | 87 | 0.010 |
Why?
| Sequence Homology, Amino Acid | 1 | 2003 | 376 | 0.010 |
Why?
| Intracellular Membranes | 1 | 2003 | 78 | 0.010 |
Why?
| Guinea Pigs | 1 | 2002 | 152 | 0.010 |
Why?
| DNA Polymerase beta | 1 | 2002 | 5 | 0.010 |
Why?
| Permeability | 1 | 2003 | 155 | 0.010 |
Why?
| Estrone | 1 | 2002 | 36 | 0.010 |
Why?
| DNA Polymerase I | 1 | 2002 | 26 | 0.010 |
Why?
| Ions | 1 | 2002 | 64 | 0.010 |
Why?
| Linoleic Acid | 1 | 2002 | 41 | 0.010 |
Why?
| S-Nitrosoglutathione | 1 | 2002 | 6 | 0.010 |
Why?
| Isoelectric Focusing | 1 | 2002 | 38 | 0.010 |
Why?
| Respiratory Burst | 1 | 2002 | 33 | 0.010 |
Why?
| Cell Line, Transformed | 1 | 2002 | 140 | 0.010 |
Why?
| PC12 Cells | 1 | 2002 | 37 | 0.010 |
Why?
| Membrane Potentials | 1 | 2003 | 273 | 0.010 |
Why?
| Free Radicals | 1 | 2002 | 100 | 0.010 |
Why?
| Insulinoma | 1 | 2002 | 31 | 0.010 |
Why?
| Electrons | 1 | 2002 | 73 | 0.010 |
Why?
| Dogs | 1 | 2002 | 382 | 0.010 |
Why?
| Hormone Replacement Therapy | 1 | 2002 | 80 | 0.010 |
Why?
| Clone Cells | 1 | 2002 | 255 | 0.010 |
Why?
| Cytotoxicity, Immunologic | 1 | 2002 | 204 | 0.010 |
Why?
| Hyperoxia | 1 | 2003 | 112 | 0.010 |
Why?
| Oligonucleotides | 1 | 2002 | 141 | 0.010 |
Why?
| Mitogen-Activated Protein Kinases | 1 | 2003 | 306 | 0.010 |
Why?
| Gene Rearrangement | 1 | 2002 | 141 | 0.010 |
Why?
| Mice, SCID | 1 | 2002 | 339 | 0.010 |
Why?
| Occupational Exposure | 1 | 2004 | 298 | 0.010 |
Why?
| Protein Biosynthesis | 1 | 2003 | 408 | 0.010 |
Why?
| Models, Chemical | 1 | 2002 | 273 | 0.010 |
Why?
| Heart Ventricles | 1 | 2006 | 741 | 0.010 |
Why?
| Mice, Transgenic | 1 | 2006 | 2079 | 0.010 |
Why?
| Diabetes Mellitus, Experimental | 1 | 2002 | 213 | 0.010 |
Why?
| Oxygen Consumption | 1 | 2002 | 613 | 0.010 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2002 | 839 | 0.010 |
Why?
| Aorta | 1 | 2002 | 368 | 0.010 |
Why?
| Glomerular Filtration Rate | 1 | 2003 | 697 | 0.010 |
Why?
| Amino Acid Sequence | 1 | 2003 | 2123 | 0.010 |
Why?
| Swine | 1 | 2002 | 777 | 0.010 |
Why?
| Estradiol | 1 | 2002 | 477 | 0.010 |
Why?
| Cattle | 1 | 2002 | 994 | 0.010 |
Why?
| Mass Spectrometry | 1 | 2002 | 686 | 0.010 |
Why?
| Fatty Acids | 1 | 2002 | 410 | 0.010 |
Why?
| Molecular Sequence Data | 1 | 2003 | 2933 | 0.010 |
Why?
| Fetus | 1 | 2003 | 699 | 0.010 |
Why?
| Survival Rate | 1 | 2003 | 1810 | 0.010 |
Why?
| Receptors, Antigen, T-Cell | 1 | 2002 | 656 | 0.010 |
Why?
| Calcium | 1 | 2002 | 1244 | 0.010 |
Why?
| Kidney | 1 | 2003 | 1355 | 0.010 |
Why?
| Mutation | 1 | 2006 | 3493 | 0.010 |
Why?
| Magnetic Resonance Imaging | 1 | 2006 | 3264 | 0.010 |
Why?
| Infant, Newborn | 1 | 2003 | 5430 | 0.010 |
Why?
| Breast Neoplasms | 1 | 2002 | 1994 | 0.010 |
Why?
|
|
Day's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|